A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium ...

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell ...

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium ...

MCLA-145 is under clinical development by Merus and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

Cui conducts basic and translational research on head and neck squamous cell carcinoma, one of the most aggressive malignancies in the oral cavity. His research aims to identify novel molecular ...

Post-operative nivolumab significantly improved disease-free survival in resected locally advanced head and neck cancer, ...

Head and neck cancer includes malignancies of the oral cavity, nasopharynx, oropharynx, hypopharynx, and larynx, and is collectively the sixth most common cancer worldwide, having accounted for ...

The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck ...

Baizean is indicated as a treatment for patients with locally advanced or metastatic esophageal squamous cell carcinoma (ESCC ... adenoid cystic carcinoma, nasopharyngeal cancer, renal pelvis cancer, ...